BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

479 related articles for article (PubMed ID: 25044020)

  • 41. Synaptotagmin-7 phosphorylation mediates GLP-1-dependent potentiation of insulin secretion from β-cells.
    Wu B; Wei S; Petersen N; Ali Y; Wang X; Bacaj T; Rorsman P; Hong W; Südhof TC; Han W
    Proc Natl Acad Sci U S A; 2015 Aug; 112(32):9996-10001. PubMed ID: 26216970
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Degradation, receptor binding, insulin secreting and antihyperglycaemic actions of palmitate-derivatised native and Ala8-substituted GLP-1 analogues.
    Green BD; Gault VA; Mooney MH; Irwin N; Harriott P; Greer B; Bailey CJ; O'Harte FP; Flatt PR
    Biol Chem; 2004 Feb; 385(2):169-77. PubMed ID: 15101559
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Novel dual agonist peptide analogues derived from dogfish glucagon show promising in vitro insulin releasing actions and antihyperglycaemic activity in mice.
    O'Harte FP; Ng MT; Lynch AM; Conlon JM; Flatt PR
    Mol Cell Endocrinol; 2016 Aug; 431():133-44. PubMed ID: 27179756
    [TBL] [Abstract][Full Text] [Related]  

  • 44. AWRK6, a Novel GLP-1 Receptor Agonist, Attenuates Diabetes by Stimulating Insulin Secretion.
    Wang Q; Zhao C; Jin L; Zhang H; Miao Q; Liu H; Zhang D
    Int J Mol Sci; 2018 Oct; 19(10):. PubMed ID: 30301245
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Characterization of Zinc Influx Transporters (ZIPs) in Pancreatic β Cells: ROLES IN REGULATING CYTOSOLIC ZINC HOMEOSTASIS AND INSULIN SECRETION.
    Liu Y; Batchuluun B; Ho L; Zhu D; Prentice KJ; Bhattacharjee A; Zhang M; Pourasgari F; Hardy AB; Taylor KM; Gaisano H; Dai FF; Wheeler MB
    J Biol Chem; 2015 Jul; 290(30):18757-69. PubMed ID: 25969539
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Type VIII adenylyl cyclase in rat beta cells: coincidence signal detector/generator for glucose and GLP-1.
    Delmeire D; Flamez D; Hinke SA; Cali JJ; Pipeleers D; Schuit F
    Diabetologia; 2003 Oct; 46(10):1383-93. PubMed ID: 13680124
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Geniposide acutely stimulates insulin secretion in pancreatic β-cells by regulating GLP-1 receptor/cAMP signaling and ion channels.
    Zhang Y; Ding Y; Zhong X; Guo Q; Wang H; Gao J; Bai T; Ren L; Guo Y; Jiao X; Liu Y
    Mol Cell Endocrinol; 2016 Jul; 430():89-96. PubMed ID: 27126219
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Glucagon-like peptide-1 increases beta-cell glucose competence and proliferation by translational induction of insulin-like growth factor-1 receptor expression.
    Cornu M; Modi H; Kawamori D; Kulkarni RN; Joffraud M; Thorens B
    J Biol Chem; 2010 Apr; 285(14):10538-45. PubMed ID: 20145256
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Engineered beta-cells secreting dipeptidyl peptidase IV-resistant glucagon-like peptide-1 show enhanced glucose-responsiveness.
    Islam MS; Rahman SA; Mirzaei Z; Islam KB
    Life Sci; 2005 Jan; 76(11):1239-48. PubMed ID: 15642594
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Glucagon-like peptide 1-potentiated insulin secretion and proliferation of pancreatic β-cells.
    Ma X; Guan Y; Hua X
    J Diabetes; 2014 Sep; 6(5):394-402. PubMed ID: 24725840
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Differential impact of amino acid substitutions on critical residues of the human glucagon-like peptide-1 receptor involved in peptide activity and small-molecule allostery.
    Koole C; Wootten D; Simms J; Miller LJ; Christopoulos A; Sexton PM
    J Pharmacol Exp Ther; 2015 Apr; 353(1):52-63. PubMed ID: 25630467
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Theoretical Investigations into the Quantitative Mechanisms Underlying the Regulation of [cAMP]i, Membrane Excitability and [Ca(2+)]i during GLP-1 Stimulation in Pancreatic β Cells].
    Takeda Y
    Yakugaku Zasshi; 2016; 136(3):467-71. PubMed ID: 26935088
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Stapled, Long-Acting Xenopus GLP-1-Based Dual GLP-1/Glucagon Receptor Agonists with Potent Therapeutic Efficacy for Metabolic Disease.
    Han C; Sun Y; Yang Q; Zhou F; Chen X; Wu L; Sun L; Han J
    Mol Pharm; 2021 Aug; 18(8):2906-2923. PubMed ID: 34240881
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A Targeted RNAi Screen Identifies Endocytic Trafficking Factors That Control GLP-1 Receptor Signaling in Pancreatic β-Cells.
    Buenaventura T; Kanda N; Douzenis PC; Jones B; Bloom SR; Chabosseau P; Corrêa IR; Bosco D; Piemonti L; Marchetti P; Johnson PR; Shapiro AMJ; Rutter GA; Tomas A
    Diabetes; 2018 Mar; 67(3):385-399. PubMed ID: 29284659
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Evidence for paracrine/autocrine regulation of GLP-1-producing cells.
    Kappe C; Zhang Q; Holst JJ; Nyström T; Sjöholm A
    Am J Physiol Cell Physiol; 2013 Nov; 305(10):C1041-9. PubMed ID: 23986202
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Design, synthesis and in vitro characterization of Glucagon-Like Peptide-1 derivatives for pancreatic beta cell imaging by SPECT.
    Behnam Azad B; Rota VA; Breadner D; Dhanvantari S; Luyt LG
    Bioorg Med Chem; 2010 Feb; 18(3):1265-72. PubMed ID: 20056547
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Potentiation of insulin secretion and improvement of glucose intolerance by combining a novel G protein-coupled receptor 40 agonist DS-1558 with glucagon-like peptide-1 receptor agonists.
    Nakashima R; Yano T; Ogawa J; Tanaka N; Toda N; Yoshida M; Takano R; Inoue M; Honda T; Kume S; Matsumoto K
    Eur J Pharmacol; 2014 Aug; 737():194-201. PubMed ID: 24858371
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Two incretin hormones GLP-1 and GIP: comparison of their actions in insulin secretion and β cell preservation.
    Yabe D; Seino Y
    Prog Biophys Mol Biol; 2011 Nov; 107(2):248-56. PubMed ID: 21820006
    [TBL] [Abstract][Full Text] [Related]  

  • 59. GRK2 regulates GLP-1R-mediated early phase insulin secretion in vivo.
    Arcones AC; Vila-Bedmar R; Mirasierra M; Cruces-Sande M; Vallejo M; Jones B; Tomas A; Mayor F; Murga C
    BMC Biol; 2021 Mar; 19(1):40. PubMed ID: 33658023
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Hindbrain GLP-1 receptor-mediated suppression of food intake requires a PI3K-dependent decrease in phosphorylation of membrane-bound Akt.
    Rupprecht LE; Mietlicki-Baase EG; Zimmer DJ; McGrath LE; Olivos DR; Hayes MR
    Am J Physiol Endocrinol Metab; 2013 Sep; 305(6):E751-9. PubMed ID: 23900416
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.